Several contemporary formulations of hormone therapy administered during the menopausal transition carry some degree of cardiovascular risk, Swedish registry data affirm. Most consistent was an ...

While the treatment is primarily used for symptoms associated with menopause in women, it has also had its fair share of ...

Hormone therapies for menopause will no longer carry a black box warning about serious risks such as breast cancer, heart attack and stroke, the Food and Drug Administration announced Monday. In the ...

With the removal of FDA warning labels, hormone therapy to treat symptoms of menopause has grown in popularity. Now some ...

WASHINGTON -- Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about stroke, heart attack, dementia and other serious risks, the ...

Women who start hormone replacement therapy (HRT) within a year after menopause may have a lower risk of developing osteoporosis, according to research presented at the American Academy of Orthopaedic ...

US health authorities are set Thursday to reassess Hormone Replacement Therapy (HRT), a treatment used by menopausal women around the world but long clouded by debate over its risks. HRT is taken to ...

Menopausal hormone therapy (commonly known as hormone replacement therapy or HRT) is not associated with an increased risk of death, finds a Danish study of over 800,000 women published in The BMJ.

Estrogen may help protect against hypertension in premenopause, a new study suggests, raising further questions about the role that hormone therapy may play in cardiovascular health later in life.

Real-world data from more than 137,000 women shows early HRT significantly improves long term bone health ...